420 related articles for article (PubMed ID: 19682191)
1. Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage.
Lim YJ; Lee JS; Ku YS; Hahm KB
J Gastroenterol Hepatol; 2009 Jul; 24(7):1169-78. PubMed ID: 19682191
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatories and gastroduodenal damage: therapeutic options.
Agrawal NM
Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroid anti-inflammatory drug-induced gastroduodenal injury.
Lai LH; Chan FK
Curr Opin Gastroenterol; 2009 Nov; 25(6):544-8. PubMed ID: 19696667
[TBL] [Abstract][Full Text] [Related]
4. [An open study on the efficacy and safety of misoprostol in prevention or treatment of gastroduodenal lesions induced by NSAID: preliminary data].
Passiu G
Clin Ter; 1991 Dec 15-31; 139(5-6):191-2. PubMed ID: 1802506
[No Abstract] [Full Text] [Related]
5. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
6. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
Goldstein JL; Larson LR; Yamashita BD
Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risks of cyclooxygenase inhibition.
Stacy ZA; Dobesh PP; Trujillo TC
Pharmacotherapy; 2006 Jul; 26(7):919-38. PubMed ID: 16803424
[TBL] [Abstract][Full Text] [Related]
8. [Guideline 'NSAID use and the prevention of gastric damage'].
Moens HJ; van Croonenborg JJ; Al MJ; van den Bemt PM; Lourens J; Numans ME;
Ned Tijdschr Geneeskd; 2004 Mar; 148(13):604-8. PubMed ID: 15083624
[TBL] [Abstract][Full Text] [Related]
9. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
Lane ME; Kim MJ
J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
Hermann M; Ruschitzka F
Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
[TBL] [Abstract][Full Text] [Related]
11. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.
Wallace JL; Vong L
Curr Opin Investig Drugs; 2008 Nov; 9(11):1151-6. PubMed ID: 18951293
[TBL] [Abstract][Full Text] [Related]
12. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
13. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
Lazzaroni M; Battocchia A; Bianchi Porro G
Dig Liver Dis; 2007 Jun; 39(6):589-96. PubMed ID: 17459794
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
15. Prevention of NSAID-induced gastroduodenal complications.
Hiele M
Clin Rheumatol; 1996 Sep; 15(5):431-4. PubMed ID: 8894354
[No Abstract] [Full Text] [Related]
16. Gastroduodenal pathophysiology of NSAIDS. Short summaries of the slides.
Odes HS; Delgado JL
Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():58-60. PubMed ID: 15146798
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
Coruzzi G; Venturi N; Spaggiari S
Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
van den Bemt BJ; Benraad HB; Rasker JJ
Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414
[TBL] [Abstract][Full Text] [Related]
19. Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology.
Kangwan N; Park JM; Hahm KB
Curr Opin Pharmacol; 2014 Dec; 19():17-23. PubMed ID: 24956584
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
